Get in touch

Welcome to the September 2024 issue of Pharmafocus! 
This issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year's CPHI in Milan! 

September 2024 issue of Pharmafocus! 
Including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on KEYTRUDA, articles on precision medicine & oral peptides PLUS a guide to CPHI in Milan! 

Pharmafocus September 2024

trade-gothic-lt

trade-gothic-lt-bold

Magazines

Pharmaceutical Industry news, analysis and insights

Pharmafocus

Pharmafile.com

Pharmafile Magazine

Samedan